136
Views
3
CrossRef citations to date
0
Altmetric
Review

Utility of a clinical scoring system in prioritizing TB investigations – a systematic review

, &
Pages 475-488 | Received 07 Feb 2019, Accepted 28 May 2019, Published online: 05 Jun 2019

References

  • World Health Organization. Global tuberculosis report. Geneva, Switzerland: World Health Organization; 2017. WHO/HTM/TB/2017.23. Available from: http://apps.who.int/medicinedocs/documents/s23360en/s23360en.pdf
  • Lawn SD, Zumla AI. Tuberculosis. Lancet. 2011 Jul 2;378(9785):57–72.
  • Müller A. Extrapulmonary TB [Internet]. Global TB Community Advisory Board; 2016. cited 2018 oct 28. Available from: http://www.tbonline.info/posts/2016/3/31/extrapulmonary-tb/.
  • Knechel NA. Tuberculosis: pathophysiology, clinical features, and diagnosis. Crit Care Nurse. 2009 Apr;29(2):34–43. quiz 44.
  • World Health Organization. Tuberculosis - key facts [Internet]. World Health Organization; 2018. cited 2018 oct 21. Available from: http://www.who.int/en/news-room/fact-sheets/detail/tuberculosis
  • Kuaban C, Koulla-Shiro S, Lekama Assiene T, et al. Tuberculosis screening of patient contacts in 1993 and 1994 in Yaounde, Cameroon. Med Trop (Mars). 1996;56(2):156–158.
  • Floyd K, Glaziou P, Zumla A, et al. The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB era. Lancet Respir Med. 2018 Apr;6(4):299–314.
  • World Health Organization. Global tuberculosis report. Geneva, Switzerland: World Health Organization; 2018. WHO/CDS/TB/2018.20. Available from http://apps.who.int/iris/bitstream/handle/10665/274453/9789241565646-eng.pdf?ua=1
  • Rahevar K, Fujiwara PI, Ahmadova S, et al. Implementing the end TB strategy in the Western Pacific Region: translating vision into reality. Respirology. 2018 Aug;23(8):735–742.
  • Mbu ET, Sauter F, Zoufaly A, et al. Tuberculosis in people newly diagnosed with HIV at a large HIV care and treatment center in Northwest Cameroon: burden, comparative screening and diagnostic yields, and patient outcomes. PLoS One. 2018;13(6):e0199634.
  • Reechaipichitkul W, Suleesathira T, Chaimanee P. Comparison of GeneXpert MTB/RIF assay with convetional AFB smear for diagnosis of pulmonary tuberculosis in northeastern Thailand. Southeast Asian J Trop Med Public Health. 2017 Mar;48(2):313–321.
  • Steingart KR, Ng V, Henry M, et al. Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis. 2006 Oct;6(10):664–674.
  • World Health Organization. Systematic screening for active tuberculosis - principles and recommendations. Geneva, Switzerland: World Health Organization; 2013. WHO/HTM/TB/2013.04. Available from: http://www.who.int/tb/publications/Final_TB_Screening_guidelines.pdf
  • Steingart KR, Schiller I, Horne DJ, et al. Xpert(R) MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2014 Jan;21(1):Cd009593.
  • Rageade F, Picot N, Blanc-Michaud A, et al. Performance of solid and liquid culture media for the detection of mycobacterium tuberculosis in clinical materials: meta-analysis of recent studies. Eur J Clin Microbiol Infect Dis. 2014 Jun;33(6):867–870.
  • Hanifa Y, Fielding KL, Chihota VN, et al. A clinical scoring system to prioritise investigation for tuberculosis among adults attending HIV clinics in South Africa. PLoS One. 2017;12(8):e0181519.
  • Shapiro AE, Hong T, Govere S, et al. C-reactive protein as a screening test for HIV-associated pulmonary tuberculosis prior to antiretroviral therapy in South Africa. Aids. 2018 Aug 24;32(13):1811–1820.
  • World Health Organization. High priority target product profiles for new tuberculosis diagnostics: report of a consensus meeting. Geneva, Switzerland: World Health Organization; 2014. WHO/HTM/TB/2014.18. Available from: http://apps.who.int/iris/bitstream/handle/10665/135617/WHO_HTM_TB_2014.18_eng.pdf?sequence=1
  • World Health Organization. Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource- constrained settings. Geneva, Switzerland: World Health Organization; 2011. ISBN 978 92 4 150070 8. Available from: http://apps.who.int/iris/bitstream/handle/10665/44472/9789241500708_eng.pdf?sequence=1
  • Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009 Oct;62(10):e1–34.
  • McGinn TG, Guyatt GH, Wyer PC, et al. Users’ guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-based medicine working group. Jama. 2000 Jul 5;284(1):79–84.
  • Mosimaneotsile B, Talbot EA, Moeti TL, et al. Value of chest radiography in a tuberculosis prevention programme for HIV-infected people, Botswana. Lancet. 2003 Nov 8;362(9395):1551–1552.
  • Pf W, Aw R, Me W, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011 Oct 18;155(8):529–536.
  • Balcha TT, Skogmar S, Sturegard E, et al. A clinical scoring algorithm for determination of the risk of tuberculosis in HIV-infected adults: a cohort study performed at Ethiopian health centers. Open Forum Infect Dis. 2014 Dec;1;3:ofu095.
  • Yoon C, Semitala FC, Atuhumuza E, et al. Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy study. Lancet Infect Dis. 2017 Dec;17(12):1285–1292.
  • Claassens MM, van Schalkwyk C, Floyd S, et al. Symptom screening rules to identify active pulmonary tuberculosis: findings from the Zambian South African tuberculosis and HIV/AIDS reduction (ZAMSTAR) trial prevalence surveys. PLoS One. 2017;12(3):e0172881.
  • Rudolf F, Wagner AJ, Back FM, et al. Tuberculosis case finding and mortality prediction: added value of the clinical TBscore and biomarker suPAR. Int J Tuberc Lung Dis. 2017 Jan 1;21(1):67–72.
  • Drain PK, Losina E, Coleman SM, et al. Rapid urine lipoarabinomannan assay as a clinic-based screening test for active tuberculosis at HIV diagnosis. BMC Pulm Med. 2016 Nov 14;16(1):147.
  • Modi S, Cavanaugh JS, Shiraishi RW, et al. Performance of clinical screening algorithms for tuberculosis intensified case finding among people living with HIV in Western Kenya. PLoS One. 2016;11(12):e0167685.
  • Melendez J, Sanchez CI, Philipsen RH, et al. An automated tuberculosis screening strategy combining X-ray-based computer-aided detection and clinical information. Sci Rep. 2016 Apr;29(6):25265.
  • Ahmad Khan F, Verkuijl S, Parrish A, et al. Performance of symptom-based tuberculosis screening among people living with HIV: not as great as hoped. Aids. 2014 Jun 19;28(10):1463–1472.
  • Swindells S, Komarow L, Tripathy S, et al. Screening for pulmonary tuberculosis in HIV-infected individuals: AIDS clinical trials group protocol A5253. Int J Tuberc Lung Dis. 2013 Apr;17(4):532–539.
  • Rangaka MX, Wilkinson RJ, Glynn JR, et al. Effect of antiretroviral therapy on the diagnostic accuracy of symptom screening for intensified tuberculosis case finding in a South African HIV clinic. Clin Infect Dis. 2012 Dec;55(12):1698–1706.
  • Van’t Hoog AH, Meme HK, Laserson KF, et al. Screening strategies for tuberculosis prevalence surveys: the value of chest radiography and symptoms. PLoS One. 2012;7(7):e38691.
  • Nguyen DT, Hung NQ, Giang LT, et al. Improving the diagnosis of pulmonary tuberculosis in HIV-infected individuals in Ho Chi Minh City, Viet Nam. Int J Tuberc Lung Dis. 2011 Nov;15(11):1528–1534. i.
  • Rangaka MX, Gideon HP, Wilkinson KA, et al. Interferon release does not add discriminatory value to smear-negative HIV-tuberculosis algorithms. Eur Respir J. 2012 Jan;39(1):163–171.
  • Castro CB, Costa PA, Ruffino-Netto A, et al. Assessment of a clinical score for screening suspected pulmonary tuberculosis cases. Rev Saude Publica. 2011 Dec;45(6):1110–1116.
  • Bassett IV, Wang B, Chetty S, et al. Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa. Clin Infect Dis. 2010 Oct 1;51(7):823–829.
  • Corbett EL, Zezai A, Cheung YB, et al. Provider-initiated symptom screening for tuberculosis in Zimbabwe: diagnostic value and the effect of HIV status. Bull World Health Organ. 2010 Jan;88(1):13–21.
  • Den Boon S, White NW, van Lill SW, et al. An evaluation of symptom and chest radiographic screening in tuberculosis prevalence surveys. Int J Tuberc Lung Dis. 2006 Aug;10(8):876–882.
  • Samb B, Henzel D, Daley CL, et al. Methods for diagnosing tuberculosis among in-patients in eastern Africa whose sputum smears are negative. Int J Tuberc Lung Dis. 1997 Feb;1(1):25–30.
  • World Health Organization. Early detection of tuberculosis: an overview of approaches, guidelines and tools. Geneva, Switzerland: World Health Organization; 2011; WHO/HTM/STB/PSI/2011.21. Available from: http://apps.who.int/iris/bitstream/handle/10665/70824/WHO_HTM_STB_PSI_2011.21_eng.pdf?sequence=1
  • Denkinger CM, Nicolau I, Ramsay A, et al. Are peripheral microscopy centres ready for next generation molecular tuberculosis diagnostics? Eur Respir J. 2013 Aug;42(2):544–547. [Letter To the Editor].
  • Gualano G, Mencarini P, Lauria FN, et al. Tuberculin skin test - Outdated or still useful for Latent TB infection screening? Int J Infect Dis. 2019 Mar;80s:S20–s22.
  • Holden M, Dubin MR, Diamond PH. Frequency of negative intermediate-strength tuberculin sensitivity in patients with active tuberculosis. N Engl J Med. 1971 Dec 30;285(27):1506–1509.
  • Samandari T, Bishai D, Luteijn M, et al. Costs and consequences of additional chest x-ray in a tuberculosis prevention program in Botswana. Am J Respir Crit Care Med. 2011 Apr 15;183(8):1103–1111.
  • Reid MJ, Shah NS. Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings. Lancet Infect Dis. 2009 Mar;9(3):173–184.
  • Agizew T, Bachhuber MA, Nyirenda S, et al. Association of chest radiographic abnormalities with tuberculosis disease in asymptomatic HIV-infected adults. Int J Tuberc Lung Dis. 2010 Mar;14(3):324–331.
  • Colebunders R, Bastian I. A review of the diagnosis and treatment of smear-negative pulmonary tuberculosis. Int J Tuberc Lung Dis. 2000 Feb;4(2):97–107.
  • Rudolf F, Joaquim LC, Vieira C, et al. The Bandim tuberculosis score: reliability and comparison with the Karnofsky performance score. Scand J Infect Dis. 2013 Apr;45(4):256–264.
  • Kranzer K, Houben RM, Glynn JR, et al. Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis. Lancet Infect Dis. 2010 Feb;10(2):93–102.
  • Maimaiti R, Zhang Y, Pan K, et al. High prevalence and low cure rate of tuberculosis among patients with HIV in Xinjiang, China. BMC Infect Dis. 2017 Jan 5;17(1):15.
  • Jamal LF, Moherdaui F. Tuberculosis and HIV infection in Brazil: magnitude of the problem and strategies for control. Rev Saude Publica. 2007 Sep;41(Suppl 1):104–110.
  • Uplekar M, Weil D, Lonnroth K, et al. WHO’s new end TB strategy. Lancet. 2015 May 2;385(9979):1799–1801.
  • Wejse C. Tuberculosis elimination in the post millennium development goals era. Int J Infect Dis. 2015 Mar;32:152–155.
  • Wejse C Bang for the buck of Xpert MTB/RIF – but less than expected. Lancet Global Health. 2019 Apr 30.
  • Dorman SE, Schumacher SG, Alland D, et al. Xpert MTB/RIF ultra for detection of mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study. Lancet Infect Dis. 2018 Jan;18(1):76–84.
  • Paris L, Magni R, Zaidi F, et al. Urine lipoarabinomannan glycan in HIV-negative patients with pulmonary tuberculosis correlates with disease severity. Sci Transl Med. 2017;9:420.
  • Pande T, Cohen C, Pai M, et al. Computer-aided detection of pulmonary tuberculosis on digital chest radiographs: a systematic review. Int J Tuberc Lung Dis. 2016 Sep;20(9):1226–1230.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.